Overview

API China (China International Pharmaceutical Ingredients, Intermediates, Packaging and Equipment Exhibition) has been deeply rooted in the Chinese pharmaceutical market for over 40 years, and has now become a crucial platform for global pharmaceutical brands to explore the Chinese market.

With the core mission of serving innovation across the entire pharmaceutical value chain, API China covers products and technologies throughout the entire process from drug R&D to production. Exhibitors span multiple fields including pharmaceutical ingredients, intermediates, natural products, pharmaceutical excipients, pharmaceutical packaging, pharmaceutical machinery, biopharmaceuticals, and pharmaceutical R&D and production outsourcing services (CRO/CDMO/CMO). The exhibition comprehensively showcases new products and technologies in China's pharmaceutical industry.

Concurrent with each edition, dozens of technical forums and seminars focus on policy trends, industry frontiers, and hot topics, disseminating advanced pharmaceutical concepts and building a business exchange platform that promotes information sharing and win-win cooperation within the pharmaceutical industry.

This featured zone focuses on the complete chain of biopharmaceuticals from "R&D" to "market." Bringing together resources across the entire supply chain including raw materials, production, cold chain, logistics, and compliance, it comprehensively links the core stages from R&D achievements to market realization. Building a platform for exhibitors to connect and exchange with over 100 innovative pharma companies and leading CRO/CDMO enterprises, it offers opportunities to seize the initiative in supply chain restructuring and share in the trillion-yuan industry's new blue ocean. Serving biopharmaceutical R&D and manufacturing companies, supply chain managers, and industry investors, it is a strategic high ground for grasping the pulse of the biopharmaceutical industry and connecting key upstream and downstream resources.

This featured zone leverages the deep heritage and extensive resources of API China's full-industry chain platform to comprehensively unlock business cooperation opportunities and technical exchange platforms for pharmaceutical R&D. The exhibits cover the entire chain from "target discovery → CMC → clinical trials → registration → commercial production." Bringing together leading service providers across drug discovery, process development, clinical research, regulatory consulting, and commercial production, it provides a one-stop R&D outsourcing resource matching platform for pharmaceutical companies, biotech firms, and research institutions. Serving pharma R&D decision-makers, CRO/CDMO enterprises, and entrepreneurs, it is a strategic window for accelerating new drug launches and integrating external R&D resources.